Div. Metabolic and Nutritional Medicine Dr. von Hauner Children's Hospital Univ. of Munich Medical Centre
Munich, Bavaria, 80337, Germany
NCT Number: NCT01951937
In the FINS study we test - in a randomized non blinded intervention study- the hypothesis that increased intake of salmon will improve cognitive performance of children aged 4 years to 6 years in the Munich area (Germany), who habitually consume little fish.
Looking for future studies?
Notify Me4 year–6 year
All sexes
Interventional
Not applicable
Munich, Bavaria, 80337, Germany
Long chain polyunsaturated fatty acids (LC-PUFA) of the n-3 series, eicosapentaenoic acid (EPA) and most prominently docosahexaenoic acid (DHA), are considered important for neural development during pre- and postnatal development.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Meals containing salmon
No fish meals
Time frame: Change from baseline at 4 months later
Time frame: Change from baseline at 4 months later
Time frame: Change from baseline at 4 months later
Time frame: Change from baseline at 4 months later
Ludwig-Maximilians - University of Munich
Other
Fish Intervention and Learning Abilities in German Youths
Acronym: FINS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06829368
Cognitive Enhancement
Nottingham, Nottinghamshire, United Kingdom
View Trial DetailsNCT06689644
Cognitive Enhancement
Leeds, United Kingdom
View Trial DetailsNCT02954679
Chemically-Induced Disorders, Cognitive Enhancement
Clermont-Ferrand, France
View Trial DetailsNCT07479914
Alzheimer Disease, Alzheimer's Disease
Monza, Lombardy, Italy
View Trial Details